ER
Insider
Elena Ridloff
DirectorElena Ridloff (Director) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Kymera Therapeutics, Inc. (KYMR). The largest single filing was $1.0M of KYMR (12,000 sh across 3 lots, as filed), executed Mar 31.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
2
0 buys · 2 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$1.3M
shares × price, as filed
Last traded
May 11
Filed May 11
Median ADV $102.3M across their filed names
Open performance→Volume by month
Buys $0
Sells $3.8M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
2 filings
Sector per market data · by filing · past 12 months
Most traded names
KYMRRecent filings
KYMRSALE
Kymera Therapeutics, Inc.
View filing →
$261K3,000 sh × $87.00
Exec May 11
Filed May 11 · 5:30 PM ET KYMRSALE Kymera Therapeutics, Inc. View filing → $1.0M
12,000 sh across 3 lots
Exec Mar 31
Filed Apr 1 · 5:30 PM ET SIONSALE Sionna Therapeutics, Inc. View filing → $222K
8,836 sh × $25.08
Exec Sep 2 2025
Filed Sep 3 2025 · 5:30 PM ET SIONSALE Sionna Therapeutics, Inc. View filing → $418K
16,098 sh × $25.97
Exec Aug 28 2025
Filed Aug 28 2025 · 5:30 PM ET SIONSALE Sionna Therapeutics, Inc. View filing → $1.1M
52,000 sh across 2 lots
Exec Aug 19 2025
Filed Aug 21 2025 · 5:30 PM ET KYMRSALE Kymera Therapeutics, Inc. View filing → $225K
4,500 sh × $50.00
Exec Jun 11 2025
Filed Jun 11 2025 · 5:30 PM ET KYMRSALE Kymera Therapeutics, Inc. View filing → $553K
12,000 sh across 2 lots
Exec Jun 3 2025
Filed Jun 3 2025 · 5:30 PM ET